US Foods Q3 Earnings Surpass Estimates, Sales Increase Y/Y

US Foods' fiscal Q3 adjusted EPS rose 17.8% year over year to $1.26, topping the $1.25 consensus, while sales increased 2.1% to $10.402 billion but missed the $10.563 billion estimate. Adjusted EBITDA grew 9.9% to $555 million and margin expanded 38 basis points to 5.3%; the company also reported $690 million of year-to-date share repurchases and improved net leverage to 2.4x from 2.7x. US Foods narrowed fiscal 2026 growth guidance, citing slower macro conditions and elevated fuel costs: sales growth to 4%-5%, adjusted EBITDA growth to 9%-11%, and adjusted EPS growth to 18%-20%.

Analysis

The setup is operationally better than the headline growth rate implies, but less clean than the EPS beat: volume growth is modest and chain demand is contracting, while margin expansion may not be fully repeatable. The favorable LIFO comparison boosted reported gross-profit growth; adjusted gross profit is the more useful read-through. If fuel inflation persists and distribution costs cannot be passed through promptly, a narrow-margin distributor can lose incremental EBITDA quickly even while sales rise. That risk is sector-wide, including Sysco, rather than unique to US Foods.

USFD’s independent-restaurant and healthcare share gains are the durable bull case: they can support route density and offset weakness in large chains. Prime Line may broaden specialty mix, but the financial contribution and integration costs are not yet established. Buybacks support per-share growth, though cash returns compete with debt reduction; leverage improvement is constructive but does not remove balance-sheet sensitivity.

Near term, the reduced growth ranges and recent share outperformance raise the bar for incremental upside. Over the next 1–3 months, watch organic case volumes, fuel cost pass-through, adjusted gross-profit growth, and whether EBITDA guidance holds. Over 6–18 months, sustained independent-channel gains and specialty integration could improve mix; persistent chain weakness or fuel-driven cost leakage would reverse the thesis. Contrarian point: the guide reduction is not a collapse in outlook, but treating EPS growth as purely operational would overstate quality given the LIFO benefit, repurchases, and modest volume growth.

Key Decisions for Investors

• Do not chase USFD after its recent rally; keep a neutral stance pending evidence that adjusted gross-profit growth and volume trends support the narrowed EBITDA range.
• For existing USFD longs, consider trimming or hedging into strength if the next update shows fuel costs rising faster than pricing recovery, or organic case growth weakening. Reassess if adjusted EBITDA guidance is cut again.
• Track Sysco as a sector read-through, not an assumed beneficiary or loser: compare case-volume trends, fuel recovery, and adjusted gross-profit growth before taking a relative-value position.
• Treat Prime Line as an unproven catalyst. Verify acquired revenue contribution, integration expense, and working-capital impact before assigning value to the specialty-mix opportunity.